Pro Share Advisors LLC Concert Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.77 - $5.24 $46,536 - $64,682	-12,344 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.86 - $13.07 $5,161 - $13,880	1,062 Added 9.41%	12,344 $62,000
Q4 2020 Feb 09, 2021	BUY	$9.48 - $12.84 $106,953 - $144,860	11,282 New	11,282 $143,000
Q2 2019 Aug 13, 2019	SELL	$9.44 - $13.12 $97,298 - $135,227	-10,307 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$12.07 - $17.54 $1,641 - $2,385	136 Added 1.34%	10,307 $124,000
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $22,297 - $32,048	-1,982 Reduced 16.31%	10,171 $128,000
Q3 2018 Nov 14, 2018	SELL	$12.82 - $17.88 $6,179 - $8,618	-482 Reduced 3.81%	12,153 $180,000
Q2 2018 Aug 13, 2018	SELL	$16.83 - $21.66 $3,113 - $4,007	-185 Reduced 1.44%	12,635 $213,000
Q1 2018 May 14, 2018	SELL	$19.24 - $28.03 $40,615 - $59,171	-2,111 Reduced 14.14%	12,820 $294,000
Q4 2017 Feb 14, 2018	BUY	$13.96 - $29.05 $208,436 - $433,745	14,931	14,931 $386,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.